O ligodendrocytes have key roles in brain development, including myelinating and electrically insulating neuronal axons for impulse propagation, as well as providing trophic and metabolic support for neurons [1] [2] [3] [4] . These functions are coordinated by communication between oligodendrocytes and neighboring astrocytes and neurons [5] [6] [7] , which occurs both through physical interactions and through secreted factors 5, [8] [9] [10] [11] . During neural development, oligodendrocyte lineage cells progress from mobile, bipolar oligodendrocyte progenitor cells (OPCs) to stationary, highly branched mature oligodendrocytes. The loss of oligodendrocytes or alterations in their ability to migrate, myelinate, or communicate with other cell types can lead to diseases such as multiple sclerosis and vanishing white matter disease 12, 13 . Although methods have been developed to generate oligodendrocytes from human pluripotent stem cells [14] [15] [16] [17] [18] , these models cannot be maintained long term in vitro and lack the diversity of mature cell types and the cytoarchitecture that oligodendrocytes encounter in vivo. These features of two-dimensional culture make the study of cellular interactions difficult as they occur in a three-dimensional (3D) environment in vivo. The advent of organoid methodologies has allowed the generation of self-organized cellular models with complex cytoarchitecture in vitro, and these cultures can be maintained over extended periods of time 19 . Here, we developed an approach to differentiate human induced pluripotent stem (hiPS) cells into 3D neural spheroids to model the development of human oligodendrocyte lineage cells alongside neurons and astrocytes. Our method produced human neurons, astrocytes, and oligodendrocytes that co-developed both spatially and temporally. The oligodendrocytes transitioned through developmental stages and were transcriptionally similar to primary oligodendrocytes. Oligodendrocyte lineage cells matured morphologically and electrophysiologically over time and ultimately myelinated nearby axons.
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Results

Generation and characterization of human oligodendrocyte spheroids (hOLS).
To generate hOLS that contain oligodendrocytes, astrocytes, and neurons, we leveraged approaches to derive regionspecific 3D cultures that we previously developed 20, 21 . We enzymatically dissociated hiPS cells into a single cell suspension (n = 7 hiPS cell lines derived from 7 control subjects; see Supplementary  Table 1 ) and aggregated them into spheroids using microwells (Fig. 1a) . After dislodging the spheroids from the microwells 18-24 h later, we exposed them to dual SMAD inhibitors dorsomorphin and SB-431542 followed by epidermal growth factor (EGF) and fibroblast growth factor 2. Smoothened agonist and IWP-2 were added to activate the SHH pathway (days [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] and inhibit the WNT pathway (days , respectively. From day 25 to day 36, we added platelet-derived growth factor (PDGF), hepatocyte growth factor, insulin-like growth factor 1, neurotrophin 3 (NT-3), brainderived neurotrophic factor (BDNF), insulin, triiodo-L-thyronine (T3), biotin, and a cyclic AMP analog (cAMP) to promote OPC survival and proliferation 14 . At day 37, insulin, biotin, T3, cAMP, and L-ascorbic acid were added to the media for the duration of culture to promote oligodendrocyte maturation. At day 25 of in vitro culture, hOLS showed high expression of the ectoderm marker SOX2, but not the mesoderm or endoderm markers BRACH and SOX17 (Supplementary Fig. 1a ; n = 4 samples from hOLS derived from 4 hiPS cell lines). At day 37, hOLS expressed the forebrain markers FOXG1, SIX3, NKX2-1, OTX2, PAX6, and LHX2 at levels comparable to or higher than our previously described method to generate human cortical spheroids (hCS) -tailed Mann-Whitney test, ****P < 0.0001), NKX2-2 (c) (two-tailed Mann-Whitney test, ****P < 0.0001), and MBP (d) (two-tailed t test, t = 2.97, d.f. = 15, ***P = 0.009). In b-d, for hCS n = 8 and for hOLS n = 9 RNA samples from spheroids derived from 4 hiPS cell lines in 1-4 differentiation experiments; see Supplementary Table 1 . Lines are shown in different colors; each point represents 2-4 hOLS pooled from 1 differentiation experiment. e-h, Day 54 immunostaining and quantification of OLIG2 and NKX2-2 double-positive cells (e,f) (two-tailed t test, t = 0.55, d.f. = 7, P = 0.59) and of PDGFRα (g,h) (two-tailed t test, t = 1.68, d.f. = 7, P = 0.13) out of Hoechst in dissociated hOLS at day 54 and day 110 (n = 5 samples each consisting of 4-6 hOLS derived from 3 hiPS cell lines; hiPS cell lines shown in different colors; see Supplementary Table 1) . i-l, Immunostaining of O4 (i), O1 (j), MBP (k), and MBP and O4 (l) in cryosections. Immunostainings were repeated on hOLS from six independent inductions for O4, three independent inductions for O1, five independent inductions for MBP, and three independent inductions for MBP and O4 together with similar results. m,n, Immunostaining (m) and quantification (n) of MBP + cells over time in whole hOLS cryosections (days 50-60: n = 12 hOLS from 5 hiPS cell lines; days 100-110: n = 17 hOLS from 5 hiPS cell lines; days 150-160: n = 9 hOLS from 4 hiPS cell lines; each point represents one hOLS; see Supplementary Table 1 ; Kruskal-Wallis test, P < 0.0001 with Dunn's multiple comparison test days 50-60 versus days 100-110, ***P = 0.0005, and days 50-60 versus days 100-110, ****P < 0.0001). o, Immunostaining of MBP, GFAP, and NF-H in hOLS cryosections. Immunostainings were repeated on hOLS from three independent inductions with similar results. Data are mean ± s.e.m. Scale bars, 10 μ m (k,o), 20 μ m (i,j,l), 50 μ m (e,g), and 100 μ m (m).
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Nature NeuroSCIeNCe determined by quantitative PCR (qPCR) compared with hCS 20 , suggesting an enrichment of oligodendrocyte lineage cells (n = 9 samples from hOLS and n = 8 samples from hCS derived from 4 hiPS cell lines; P < 0.001; Fig. 1b-d) . We next performed immunofluorescent labeling on cryosections ( Supplementary Fig. 1c ) obtained at day 51 and dissociated cultures obtained from day 54 and day 110 hOLS to test for the presence of NKX2-2
+ double-positive OPCs and PDGFRα + OPCs (Fig. 1e-h ). Approximately 12% of cells at day 54 and 9% of cells at day 110 were NKX2-2 + /OLIG2 + double-positive ( Fig. 1f ; n = 4-5 samples from hOLS derived from 3 hiPS cell lines) and approximately 51% of cells at day 54 and 35% of cells at day 110 were PDGFRα + ( Fig. 1h ; n = 4-5 samples from hOLS derived from 3 hiPS cell lines). To determine whether OPCs were maturing into oligodendrocytes over time, we immunostained cryosections obtained from hOLS at days 100-160 of in vitro differentiation. We observed O4 + , O1 + , and MBP + cells, indicating a range of oligodendrocyte stages from pre-oligodendrocytes to mature, late-stage oligodendrocytes (Fig. 1i-k) . Notably, we found both O4 + cells that were bipolar and did not express MBP, as well as O4
+ cells that were highly branched and overlapped with MBP (Fig. 1l) . To determine whether the abundance of mature oligodendrocytes increased in hOLS over time, we quantified the density of MBP + cells in whole cryosections between days 50 and 160 of differentiation. We observed an increase in the density of MBP + cells and that most MBP + cells were located in the outer third of each section (Fig. 1m,n and Supplementary Fig. 1d ; n = 9-17 hOLS from 6 hiPS cell lines; P < 0.0001).
A goal of this method was to produce oligodendrocytes in close proximity to neurons and astrocytes, so we performed immunostainings in day 100 hOLS cryosections for MBP, GFAP, and Neurofilament-H (200 kD) (NF-H). We observed both neurons and glial lineage cells in close proximity to each other (Fig. 1o) . Moreover, the relative gene expression of the neural marker RBFOX3 as determined by qPCR at day 100 was comparable between hCS and hOLS (Supplementary Fig. 1e ; P > 0.05), whereas the glial marker GFAP was expressed at a higher level in hOLS (Supplementary Fig. 1e ; P < 0.01). Quantifications in dissociated cultures revealed that approximately 45% of cells at day 54 and 20% of cells at day 110 were MAP2 + , and 8% of cells at day 54 and 21% of cells at day 110 were GFAP + (Supplementary Fig. 1f-i ; n = 4-5 samples from hOLS from 3 hiPS cell lines). To verify neurotransmitter identity in these cultures, we next used qPCR and found that hOLS expressed + hOLS-derived single cells. e, Oligodendrocyte cluster from t-SNE map in b with three distinct k-means subclusters of hOLS. f, Mean expression of oligodendrocyte-lineage-specific genes in hOLS as well as primary OPCs and mature oligodendrocytes isolated from adult human brain tissue (log 2 data normalized across rows). g, Singlecell gene expression of subcluster-specific markers in the oligodendrocyte lineage cluster. h, O4
+ single cells derived from hOLS indicated by hiPS cell line.
Nature NeuroSCIeNCe more of the GABAergic-related GAD1 gene (P < 0.01) and less of the glutamatergic-transporter-encoding SLC17A7 gene (P < 0.001) (also known as VGLUT1) than hCS ( Supplementary Fig. 1j ,k).
Single-cell RNA-sequencing (RNA-seq) of hOLS-derived oligodendrocytes. To comprehensively characterize oligodendrocyte lineage cells in hOLS, we isolated O4 + cells from day 127 hOLS by immunopanning and performed deep single-cell RNA-sequencing (Fig. 2a) . We sequenced 295 cells derived from two hiPS cell lines and compared their profiles to cells isolated from primary human fetal cortex, primary human adult cortex, and hCS 23, 24 ( Supplementary  Fig. 2a) . Clustering of all cells using the t-distributed stochastic neighbor embedding (t-SNE) 25 approach revealed distinct populations of SOX10 + oligodendrocytes, STMN2 + neurons, SOX9 + astrocytes, CX3CR1 + microglia, and FLT1 + endothelial cells (Fig. 2b,c and Supplementary Fig. 2b ). The O4 + cells derived from hOLS clustered most closely to OPCs and mature oligodendrocytes from the primary human adult cortical tissue within the SOX10 + cluster (Fig. 2d,e) . On closer inspection, the oligodendrocyte cluster contained populations of proliferating cells, OPCs and newly formed oligodendrocytes (NFOs), and myelinating oligodendrocytes derived from hOLS that had similar patterns of marker expression as primary OPCs and primary mature oligodendrocytes (Fig. 2f,g and Supplementary Fig. 2c ; also see Supplementary Fig. 3a for examples of genes differentially expressed between primary and hOLS samples). Expression of oligodendrocyte-stage-specific markers was confirmed in cells from each cluster by qPCR ( Supplementary  Fig. 2d ). Moreover, we found O4 + cells in the three oligodendrocyte subclusters in hOLS from two hiPS cell lines and a high transcriptomic consistency across lines (Pearson's r = 0.96, log normalized gene expression) ( Fig. 2h and Supplementary Fig. 2e,f) .
To further assess the developmental progression of oligodendrocyte lineage cells in hOLS, we performed Monocle analysis, which utilizes an unsupervised algorithm to reveal single-cell gene expression kinetics over time and orders cells through a biological process 26 . This analysis revealed a spectrum of oligodendrocyte lineage stages in hOLS ranging from dividing cells expressing MKI67 and TOP2A, which closely resemble primary OPCs, to mature cells expressing MOG and MBP, which closely resemble primary mature oligodendrocytes (Fig. 3a) . This analysis further identified several temporal patterns of gene expression, including some genes that were highly expressed early and decreased over pseudotime, some that peaked mid-pseudotime, and others that were more highly expressed at later pseudotime points (Fig. 3b) . Early pseudotime genes expressed in dividing oligodendrocytes included PTPRZ1, PDGFRA, and CSGP4; mid-pseudotime genes expressed in immature oligodendrocytes included SIRT2, RASGEF1B, and TMEM108; late pseudotime genes expressed in mature oligodendrocytes included MOG, GSN, and MOBP 27 ( Fig. 3c and Supplementary Fig. 3b ). Anticipating that hOLS may be useful for disease modeling, we analyzed the single-cell expression pattern of genes associated with oligodendrocyte-related disorders ( Fig. 2e and 3d and Supplementary Fig. 3c ). We found that a gene associated with Aicardi-Goutieres syndrome (RNASEH2A) 28 was expressed primarily in OPCs and NFOs, and that genes associated with metachromatic leukodystrophy (ARSA) 29 and Krabbe disease (GALC) 30 were expressed in mature oligodendrocytes. These findings suggest that having access to multiple stages of oligodendrocyte development may be important for disease modeling.
Maturation of oligodendrocytes in hOLS.
Prompted by the finding that oligodendrocyte lineage cells mature transcriptionally in hOLS, we next examined their morphology and functional properties. During development, bipolar OPCs migrate from their region of origin throughout the cortex where they ultimately cease migrating and extend multiple processes that interact with nearby neurons 31 . To determine whether OPCs migrate in hOLS as they do in vivo, we used temperature-controlled live imaging with a previously described Sox10-MCS5::eGFP reporter 32 at in vitro differentiation stages ranging from day 65 up to day 275 in culture ( Fig. 4a) . We found that the propensity of Sox10-MCS5::eGFP + cells to migrate peaked between days 110 and 180 of in vitro culture, but all Sox10-MCS5::eGFP + cells were stationary by day 235 ( Fig. 4b ; n = 5-8 hOLS from 5 hiPS cell lines; P < 0.01).
We next sought to determine whether hOLS-derived oligodendrocyte lineage cells mature electrophysiologically. As OPCs mature to multipolar oligodendrocytes, expression of voltage-gated sodium and potassium channels is progressively reduced 33, 34 . We performed whole cell current clamp recordings from bipolar and multipolar 
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Sox10-MCS5::eGFP
+ cells in slices of hOLS from days 108 to 175 (Fig. 4c) . We observed that the membrane response to current injection of bipolar cells, but not multipolar cells, was highly nonlinear, indicating expression of voltage-dependent sodium and potassium channels in the former. In fact, the I-V curve of bipolar-shaped cells showed outwardly rectifying currents suggestive of slowly inactivating potassium currents ( Fig. 4d ,e; n = 10-13 cells, P < 0.001), and this difference was accompanied by complementary differences in input resistance and capacitance ( Supplementary Fig. 4a, b) . Moreover, during oligodendrocyte development, the release of glutamate by nearby neurons plays an instructive role in OPC differentiation 35, 36 . We tested for sensitivity to released glutamate in voltage-clamped Sox10-MCS5::eGFP + cells and observed discrete inward-going events in approximately 70% of bipolar and multipolar cells (n = 13 and 10 cells, respectively; Fig. 4f ). These events were blocked by application of 40 μ M APV and 20 μ M NBQX (n = 5 cells; Fig. 4f and Supplementary Fig. 4c ), indicating that Sox10-MCS5::eGFP + cells express ionotropic glutamate receptors that are spontaneously activated in hOLS.
A hallmark of oligodendrocyte maturation is the ability to interact with and myelinate neuronal axons. We immunostained hOLS cryosections at day 115 for MBP and NF-H and observed the interaction of oligodendrocyte processes and nearby axons (Fig. 5a) . Moreover, in hOLS cryosections obtained at day 150-158, we identified examples of MBP flanking neurofilament staining, indicative of myelination (Fig. 5b,c and Supplementary Fig. 4d ). We found that, at days 150-160, ~28% of MBP + cells interacted with NF-H + processes ( Fig. 5d ; n = 9 hOLS from 3 hiPS cell lines). To verify myelination, we performed transmission electron microscopy at days 100-170 in hOLS derived from three hiPS cell lines and found various stages of myelination, including lamellae of compact myelin surrounding axons (Fig. 5e ,f and Supplementary Fig. 4e,f) . Lastly, as a proof of principle that hOLS can be used to study oligodendrocyte loss or injury, we treated day 75-85 hOLS with the toxic phospholipid lysolecithin for 15-17 h (Fig. 5g) , which has been shown to cause demyelination in vivo and in explant cultures [37] [38] [39] . Monitoring by live imaging at 4-6 h after treatment revealed changes in the morphology and loss of Sox10-MCS5::eGFP + cells (Fig. 5g,h ).
Discussion
We demonstrate the generation of human oligodendrocyte lineage cells in a 3D cellular platform that includes multiple stages of oligodendrocyte development, migration, and myelination. Our system produces neurons and astrocytes that spatially and temporally overlap with oligodendrocytes, allowing interaction between cell types. This model has several advantages over existing methods to produce oligodendrocytes in vitro, including the existence of multiple mature cell types (Supplementary Table 2 ). In addition, the 3D nature of this platform more closely resembles the cytoarchitecture and cellular milieu that oligodendrocytes would encounter in vivo. There is increasing evidence of the importance of interactions between oligodendrocytes and astrocytes and between oligodendrocytes and neurons during development both through secreted factors and physical interactions 5, [8] [9] [10] [11] , and the recapitulation of these interactions may be essential to building more realistic in vitro models of brain function and dysfunction. 
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To validate the stages of oligodendrocyte development in hOLS, we performed deep single-cell RNA-seq and identified a progression of oligodendrocyte lineage cells from dividing progenitors to mature oligodendrocytes. We additionally compared these transcriptional data to the signature of primary human oligodendrocytes isolated from human cerebral cortex and found that they clustered closely. Future studies are necessary to confirm transcriptional similarity in additional hiPS cell lines and with larger cell numbers.
The transcriptional maturation of oligodendrocyte lineage cells in hOLS was accompanied by functional changes as assessed by electrophysiology and electron microscopy. The maturation and similarity of oligodendrocytes in hOLS to primary adult samples suggest that this model can be applied to answer basic questions regarding human oligodendrocyte development, as demonstrated by the expression of white-matter-disease-related genes in single cells derived from hOLS. To study later stages of oligodendrocyte maturation and myelination, future methods need to be developed to better quantify the extent of compact myelination in 3D culture. Quantifying wrapping by traditional electron microscopy techniques is difficult as a result of inconsistency in the directionality of axons in 
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Nature NeuroSCIeNCe hOLS. However, these current limitations may be resolved by incorporating scaffolds to guide projecting axons in hOLS or by performing high-throughput electron microscopy to image larger areas of hOLS and obtain more accurate quantifications of myelination.
A remaining obstacle in the use of 3D cultures to study disease processes is the inherent inter-and intra-organoid variability that complicates the comparison between control and disease-related cultures 40 . Strategies to limit the variability between organoids include directing differentiation to specific brain regions, limiting the use of embedding in extracellular matrices that can induce spurious fates, using cell-specific reporters for imaging cell types of interest, and using single cell sequencing 19, 41 . In hOLS, the variability in OPC yield is higher at earlier stages and decreases over time. Notably, we also found that transcriptional variability is lower at later stages of hCS differentiation 42 . This suggests that, for future applications, allowing hOLS to mature to around day 100 would result in higher consistency.
This hOLS method can be used to live image multiple stages of oligodendrocyte development over long periods of time in vitro to dissect the physical mechanisms of OPC migration and myelination. Here, as a proof of principle, we demonstrate that treatment with lysolecithin induces oligodendrocyte cell loss and that this process can be monitored by live imaging. Future studies can apply this cellular model to study leukodystrophies and other disorders affecting myelination in the CNS. The hOLS have the potential to be fused with other brain region-specific spheroids to derive brain assembloids 19, 21 to study the migration and differentiation of oligodendrocyte lineage cells in different brain regions. hOLS may also potentially be combined with autologous patient-derived immune cells to study neuro-immune dysfunction, such as in multiple sclerosis. The personalized nature of the hiPS-cell-derived platform will further allow the study of these cellular processes in the context of disease, such as vanishing white matter disorder 12 , or environmental alterations, such as the effect of hypoxic injury on the premature brain 43 . The scalability of hOLS also makes this system amenable to genetic and small molecule screens to discover modulators of human myelination and identify novel therapeutics.
Online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/ s41593-018-0316-9. 
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Methods
Culture of hiPS cells. The hiPS cell lines used in this study were validated using standardized methods as previously described 44, 45 . Cultures were tested for and maintained mycoplasma free. A total of seven control hiPS cell lines derived from fibroblasts collected from seven subjects were used for experiments (Supplementary Table 1 ). The hiPS cell line H20961 was derived by the Gilad laboratory 46 . Approval for hiPS cell work was obtained from the Stanford Institutional Review Board panel and informed consent was obtained from all subjects.
Generation of hCS and hOLS from hiPS cells. hiPS cells were cultured on vitronectin-coated plates (5 μ g ml −1 , Thermo Fisher, A14700) in Essential 8 medium (Thermo Fisher, A1517001). Cells were passaged every 4 d with 0.5 mM EDTA (Life Technologies, pH 8.0).
For the generation of 3D neural spheroids, hiPS cells were incubated with accutase (Innovate Cell Technologies, AT104) at 37°C for 7 min and dissociated into single cells. To obtain uniformly sized spheroids, AggreWell-800 (Stemcell Technologies, 34815) containing 300 microwells was used. Approximately 3 × 10 6 single cells were added per AggreWell-800 well in Essential 8 medium supplemented with the ROCK inhibitor Y-27632 (10 μ M, EMD Chemicals, S1049), centrifuged to capture the cells in the microwells, and incubated at 37°C with 5% CO 2 . After 18-24 h, spheroids consisting of approximately 10,000 cells were collected from each microwell by pipetting medium in the well up and down with a cut pipet tip and transferred into ultra-low attachment plastic dishes (Thermo Fisher, 3262) in Essential 6 medium (Thermo Fisher, A1516401) supplemented with two SMAD pathway inhibitors-dorsomorphin (2.5 μ M, Sigma-Aldrich, P5499-CONF) and SB-431542 (10 μ M, R&D Systems, 1614). For the first 5 d, Essential 6 medium was changed every day and supplemented with dorsomorphin and SB-431542.
To generate hOLS, on day 6 in suspension the spheroids were transferred to differentiation and maintenance medium (DMM) containing DMEM/F12 (Thermo Fisher, 11330-057), B-27 supplement without vitamin A (Thermo Fisher, 12587010), N2 supplement (Thermo Fisher, 17502048), minimum essential media (MEM) non-essential amino acids (1:100, Thermo Fisher, 11140076), GlutaMax (1:100, Thermo Fisher, 35050079), human insulin (25 μ g ml , Sigma-Aldrich, I9278-5ML), β -mercaptoethanol (0.1 mM; Sigma-Aldrich M3148), and penicillinstreptomycin (1:100, Thermo Fisher, 15140163). The DMM was supplemented with 20 ng ml −1 EGF (R&D Systems, 236-EG-01M) and 20 ng ml −1 basic fibroblast growth factor (bFGF) (Peprotech, 100-26) for 19 d (until day 24) with daily medium change in the first 10 d, and every other day for the subsequent 9 d. The Wnt pathway inhibitor IWP-2 (5 μ M, Selleckchem, S7085) was added from day 4 until day 24, and the small molecule SHH pathway smoothened agonist (1 μ M, Millipore Sigma, 566660) was added from day 12 to day 24. From day 25 to day 36, hOLS were cultured in DMM supplemented with T3 (60 ng ml −1 , Sigma-Aldrich, T2877), biotin (100 ng ml , VWR, 100-11), and PDGF-AA (10 ng ml −1 , R&D Systems, 221-AA). From day 37 onwards, hOLS were cultured in complete DMM (DMM supplemented with T3, biotin, cAMP, and ascorbic acid; 20 μ g ml −1 , Wako Pure Chemical, 323-44822). From day 17 to day 43, media changes were performed every other day. From day 44 onwards, media changes were preformed every 4-5 d.
The generation of hCS from hiPS cells was performed similarly to a method we previously described 20 . To generate hCS, on day 6 in suspension the microwell-generated spheroids were transferred to neural medium containing Neurobasal A (Thermo Fisher, 10888022), B-27 supplement without vitamin A (Life Technologies, 12587), GlutaMax (Life Technologies, 1:100), and penicillin-streptomycin (1:100, Thermo Fisher, 15140163). Neural medium was supplemented with 20 ng ml −1 EGF (R&D Systems) and 20 ng ml −1 bFGF (R&D Systems) for 19 d (until day 24) with daily medium change in the first 10 d, and every other day for the subsequent 9 d. To promote differentiation of the neural progenitors into neurons, neural medium was supplemented with 20 ng ml Cryopreservation. hOLS were fixed in 4% paraformaldehyde (PFA) overnight. They were then washed in PBS and transferred to 30% sucrose for 3-7 d. Subsequently, they were rinsed in optimal cutting temperature (OCT) and 30% sucrose (1:1) and embedded in OCT (Tissue-Tek OCT Compound 4583, Sakura Finetek) and stored at − 80 °C. For immunofluorescence, 12-14-μ m-thick sections were cut using a Leica cryostat.
Immunofluorescence. Cryosections were washed with PBS to remove excess OCT and blocked in 10% normal donkey serum (NDS, Abcam, AB7475), 0.3% Triton X-100 (Sigma-Aldrich, X-100) diluted in PBS for 1 h at room temperature. The sections were then incubated overnight at 4 °C with primary antibodies diluted in PBS containing 10% NDS and 0.3% Triton X-100. PBS was used to wash off the primary antibodies and the cryosections were incubated with secondary antibodies in PBS with 10% NDS and 0.3% Triton X-100 for 1 h. Dissociated cultures on glass coverslips were fixed in 4% PFA in PBS for 15 min at 4 °C and then rinsed for 5 min with PBS. The coverslips were then treated with 0.1% Triton X-100 in PBS for 15 min at room temperature except for when staining for PDGFRα . The coverslips were blocked for 1 h at room temperature with 5% NDS in PBS and then incubated overnight at 4 °C with primary antibodies diluted in PBS containing 5% NDS. PBS was used to wash off the primary antibodies and the cryosections were incubated with secondary antibodies in PBS with 5% NDS for 1 h. The following primary antibodies were used for immunofluorescence: anti-OLIG2 47 (rabbit, 1:500, Millipore, AB9610), anti-NKX2-2 48 55 (rabbit, 1:1,000, Sigma, A2052), and anti-MAP2 56 (guinea pig, 1:2,500 on coverslips, 1:10,000 on cryosections, Synaptic Systems, 188004). Alexa Fluor dyes (Life Technologies) were used at 1:1,000 dilution on cryosections and 1:2,000 on coverslips for amplification of the signal. Nuclei were visualized with Hoechst 33258 (Life Technologies, H3549). Cryosections were mounted for microscopy on glass slides using Aquamount (Polysciences, 18606) and imaged on a Zeiss M1 Axioscope, Leica TCS SP8 confocal microscope, or Keyence BZ-X710. Images were processed in ImageJ (Fiji Version 2.0.0). For the analysis in Fig. 5d , the proportion of MBP + cells overlapping for more than 1 μ m with NF-H in 0.5-μ m z-sections was counted.
Dissociation and immunopanning of hOLS.
For the enzymatic dissociation of hOLS for culture in monolayer and immunocytochemistry, hOLS were incubated with accutase for 30 min at 37 °C, washed with 10% fetal bovine serum (FBS) (Thermo Fisher, 16000-044) in Hank's balanced salt solution (HBSS) (Thermo Fisher, 14180046), and gently triturated using a P200 pipette. Cells were centrifuged and resuspended in complete DMM. The cells were plated on glass coverslips (15 mm, Warner Instruments, 640713) coated with poly-L-ornithine (50 μ g ml
, Sigma-Aldrich, P3655) and laminin (5 μ g ml
, Sigma-Aldrich, L2020) at a density of around 1 spheroid per 2 coverslips.
To dissociate and isolate O4 + cells from hOLS for single cell profiling, we adapted a previously published protocol used for primary human fetal brain tissue 27 . Plastic Petri plates (10-cm, Thomas Scientific, 351058) were coated with 20 μ l anti-mouse IgG (Thermo Fisher, A-21042) in 7 ml 50 mM Tris-HCl pH9.5 (Fisher Scientific, T1095) at 4 °C overnight. The following day, each plate was rinsed 3 times with PBS and then coated with 1.78 μ l anti-O4 hybridoma (obtained from the B.A. Barres laboratory at Stanford University 27 ) in 2.55 ml 0.02% BSA diluted in PBS (Caisson Labs, PBL02) at room temperature for at least 3 h and rinsed 4-5 times with PBS before use. Up to 6 spheroids per immunopanning plate were dissociated with accutase as described above and resuspended in 10 ml 0.02% BSA. The resulting suspension was added to a precoated plastic Petri culture dish for at least 40 min with gentle occasional swirling. The supernatant was then removed from the O4-treated plates and the plates were rinsed with PBS 6-8 times to remove unattached cells. O4
+ cells were detached from the plates using 0.25% trypsin (Thermo Fisher, 25200056) for 5 min at 37 °C. Cells were washed in DMEM (Thermo Fisher, 10313-039) containing FBS and centrifuged for 5 min at 1,200 r.p.m., and resuspended in 0.02% BSA and supplemented with Y-27632 (10 μ M, EMD Chemicals, S1049). The suspension was filtered through a 40-μ m strainer (Fisher Scientific, 352340) and single cells were sorted into lysis buffer, 4 μ l each in 96-well plates (Bio-Rad, HSP9631). The lysis buffer contains 4 enzyme units (U) of RNase inhibitor (40 U μ l −1 , Clontech, 2313B), 0.05% Triton, 2.5 mM deoxynucleotide triphosphates (dNTP), 2.5 μ M Oligo-dT 30 VN (IDT, RNase-free HPLC purification) 57 , external RNA control consortium (ERCC) RNA Spike-In Mix (1:2.4 × 10 7 diluted, Thermo Fisher, 4456740). Plates were briefly vortexed and spun down before being stored in a -80 °C freezer until downstream processing.
Single cell RNA-seq library preparation. Sorted cells (n = 332) in 96-well plates were thawed on ice and immediately used for library preparation following the Smartseq2 protocol 57 with modifications. Briefly, plates were incubated at 72 °C for 3 min, during which RNA molecules with polyA tails were annealed with OligodT 30 VN, and then they were immediately chilled on ice. Reverse transcription mixture was added at 6 μ l per well so that the final solution contained 95 enzyme units (U) SMARTScribe Reverse Transcriptase (100 U μ l Amplified cDNA was then purified using PCRClean DX beads (~0.7 volume, Aline Biosciences, C-1003-50), and reconstituted in 20 μ l elution buffer (EB). The cDNA quality and quantity were assessed using a fragment analyzer (AATI, High Sensitivity NGS Fragment Analysis Kit: 1-6,000 base pairs (bp)), and samples with Technical RepoRT Nature NeuroSCIeNCe concentrations below 0.08 ng μ l −1 or abnormal peak patterns were filtered out. A total of 295 cDNA samples (retaining 88.9% of initially sorted) were diluted down to 0.15 ng μ l −1 (only if above it) and pooled into a 384-well plate using a Mosquito X1 (TTP Labtech). Library preparation was performed using Nextera XT DNA Sample Prep Kit (Illumina, FC-131-1096) and Nextera XT 384 dual index primers, with the help of a Mosquito HTS machine for liquid transfer. For the tagmentation step, 0.4 μ l cDNA (30-60 pg), 0.4 μ l Tagment Enzyme, and 0.8 μ l Tagment DNA Buffer were mixed and incubated at 55 °C for 10 min, followed by neutralization (0.4 μ l Neutralize Tagment Buffer). Indexes (0.5 μ M each) were added along with Nextera PCR Master Mix to a final volume of 4 μ l in each well. PCR was performed as follows: (1) Single-cell RNA-sequencing and quality control. In total, 332 single cells using 101-bp paired end reads were sequenced on a HiSeq 4000 (Illumina). Raw reads were preprocessed and aligned to the human genome (hg38) using the pipeline described in ref. 23 , which includes Spliced Transcripts Alignment to a Reference (STAR) alignment and feature counts. As a quality metric, we first performed hierarchical clustering on all cells using a list of housekeeping genes and removed any cells with uniformly low expression across all genes. We separated the resulting dendrogram into two clusters containing cells that passed or failed this quality control. All downstream analyses were performed using only the 295 cells that passed quality control. After quality control and mapping, there was an average of 509,376 mapped reads per cell. These 295 cells were added to data from single cells collected in previous studies (adult cells from ref. 23 , hCS from ref.
24
) for a total of n = 1,473 cells. Cells from each of these studies were collected using identical protocols and sequencing methods. To control for unwanted variation in batch effects, all cells were normalized using Remove Unwanted Variation (RUVg) methods 58 with the following normalization genes: CYC1, EIF4A2, SDHA, ACTB, UBC, TOP1, RPL13A, GAPDH 59 . Dimensionality reduction, clustering, and Monocle analysis. All data analyses were performed using the R software (https://www.r-project.org/). Dimensionality reduction was performed in three steps. First, we calculated the overdispersion of each gene as described in ref. 60 . We then selected the top 2,000 over-dispersed genes and constructed a cell-to-cell distance matrix (1 minus absolute correlation) of all cells (using either O4 immunopanned alone, or O4 immunopanned cells along with primary human single cells from ref. 23 and ref. 24 . The distance matrix was reduced to two dimensions using t-SNE 25 . Clustering of groups of similar cells was performed on the two-dimensional t-SNE space using k-means. The lineage tree for the single cells was constructed using the Monocle algorithm 2.0 as described in ref. 26 . The lineage trees included all O4 immunopanned single cells as well as primary adult human OPCs and oligodendrocytes from ref. 23 . t-SNE plots were colored by hiPS cell line using metadata provided in the Gene Expression Omnibus accession GSE115011. These metadata were also used to determine the proportion of dividing, immature (OPCs and NFOs), and mature myelinating oligodendrocytes (as defined by the k-means clustering of the t-SNE space described above) attributed to each hiPS cell line. Correlations between hiPS cell lines were calculated using Pearson correlation values between the log normalized gene expression data for each group. Viral labeling and assembly of neural spheroids. The viral infection of the 3D neural spheroids was performed as previously described 20, 61 . In brief, hOLS were transferred to a 1.5-ml microcentrifuge Eppendorf tube containing 300 μ l complete DMM with virus and incubated overnight. The next day, hOLS were transferred into fresh complete DMM in ultra-low attachment plates. Lentivirus (lenti-Sox10-MCS5::eGFP + ; construct reported and received from F.J. Sim Live cell imaging and analysis of Sox10-MCS5::eGFP + cell migration. The migration of Sox10-MCS5::eGFP + cells was imaged for 8-12 h under environmentally controlled conditions (37 °C, 5% CO 2 ) in intact hOLS using a confocal microscope with a motorized stage (Leica SP8). The hOLS were transferred to a well in a 96-well glass-bottom plate (Thomas Scientific, 4580) in 200 μ l complete DMM and incubated in an environmentally controlled chamber for 15-30 min before imaging. During a given recording session, up to 6 hOLS were imaged at a depth of 60-70 μ m and at a rate of 13-20 min per frame.
Real-time qPCR. mRNA was isolated using the RNeasy Mini kit (Qiagen, 74106) and RNase-Free DNAse I kit (Thermo Fisher, 18068-015), and template cDNA was prepared by reverse transcription using the SuperScript III First-Strand Synthesis SuperMix for qRT-PCR (Thermo Fisher, 11752250). qPCR was performed using SYBR Green (Thermo Fisher, 4312704) on a ViiA7 machine (Applied Biosystems, Life Technologies). Primers used are listed in Supplementary Table 3 .
Transmission electron microscopy. hOLS were fixed in 2% glutaraldehyde and 4% PFA in 0.1 M sodium cacodylate buffer, pH 7.4, for 1 h at room temperature. After fixation, samples were then moved to 4 °C for immediate processing. The buffer was removed and replaced with 1% OsO 4 in double distilled H 2 O (ddH 2 O) and the hOLS were gently shaken for 1 h at 4 °C. Samples were washed 3 times for 5 min each with cold ddH 2 O. After the third rinse the hOLS were kept in 1% uranyl acetate in ddH 2 O, and stained for 2 h to overnight. The hOLS were then dehydrated by rinsing for 10 min each in 50% ethanol at 4 °C, 70% ethanol at 4 °C, 95% ethanol at room temperature, and 100% ethanol at room temperature. A second 10-min rinse in 100% ethanol was performed followed by a 15-min rinse in acetonitrile at room temperature. The hOLS were transferred to 1:1 acetonitrile/epon for 1 h and then to 1:2 acetonitrile/epon overnight. The following day, the hOLS were placed in 100% epon for 2-3 h and then placed in molds filled with 100% epon and allowed to settle for 4 h to overnight. The molds were then polymerized in a 65 °C oven for 24 h. Samples were sectioned and imaged using a JEOL JEM1400 120-kV transmission electron microscope.
Electrophysiology. Sections of hOLS at days 96-175 of differentiation were obtained using an approach we previously described 20 . Briefly, hOLS were incubated in bicarbonate-buffered artificial cerebrospinal fluid (aCSF) at 23 °C and equilibrated with a mixture of 95% O 2 and 5% CO 2 . The aCSF solution contained: 126 mM NaCl, 26 mM NaHCO 3 , 10 mM glucose, 2.5 mM KCl, 1.25 mM NaH 2 PO 4 , 1 mM MgSO 4 , and 2 mM CaCl 2 . Slicing was performed using a Leica VT1200 vibratome. Immediately after sectioning, slices were moved to a circulation chamber containing oxygenated aCSF at room temperature.
For patch-clamp recording, cells were identified by the presence of the Sox10-MCS5::eGFP fluorescent reporter using an upright microscope (Scientifica). Recording electrodes of borosilicate glass had a resistance of 4-6 MΩ when filled with internal solution. The internal solution contained: 145 mM K-gluconate, 0.1 mM CaCl 2 , 2.5 mM MgCl 2 , 10 mM HEPES, 0.2 mM EGTA, and 4 mM Na-phosphocreatine. Glutamatergic currents were blocked by application of NBQX (20 μ M, Tocris) and APV (100 μ M, Tocris), which were added to the bathing solution. Electrical simulation was delivered using a bipolar tungsten electrode (FHS) placed 100-200 μ m away from a recorded cell. Stimulations were delivered to slices for 0.1 ms at 300 μ V and separated by at least 10 s. Voltage-gated sodium channels were blocked by application of tetrodotoxin (TTX) (1 μ M, Tocris). All recordings were performed at room temperature (25 °C). Measurements were corrected for a liquid junction potential of 12 mV.
Data were collected using a 1550A digitizer (Molecular Devices) and a 700B patch-clamp amplifier (Molecular Devices), and were acquired with pClamp 10.6 software (Molecular Devices). Data were low-pass filtered at 10 kHz and digitized at 20 kHz. Averaging, digital subtraction of null traces, and current peak detection were performed using Clampfit (Molecular Devices). Data were fitted using Origin (OriginLab).
Lysolecithin treatment and live imaging. Lysolecithin was dissolved at a concentration of 0.25 mg ml −1 in complete DMM and added to day 70-75 hOLS in 1.5-ml Eppendorf tubes for 15-17 h at 37 °C. Following treatment, hOLS were rinsed twice with complete DMM. Untreated and treated hOLS were transferred to a well of a 96-well glass-bottom plate (Thomas Scientific, 4580) in 200 μ l complete DMM 4-6 h after rinsing, and incubated in an environmentally controlled chamber for 15-30 min before imaging. During a given recording session, hOLS were imaged at a depth of 60-70 μ m and at a rate of 10-15 min per frame for 12 h. Quantification of Sox10-MCS5::eGFP + disappearing cells was performed blind.
Statistics and reproducibility. Data are presented as mean ± s.e.m. unless otherwise indicated. Distribution of the raw data was tested for normality of distribution; statistical analyses were performed using the Student's t-test (two-sided), Mann-Whitney U-test (two-sided), or Kruskall-Wallis tests. Sample sizes were estimated empirically. One hOLS sample was removed in the qPCR analysis of VGLUT1 in Supplementary Fig. 1j following Grubb's test for outliers (P < 0.05). No statistical methods were used to determine sample size, but sample sizes for each type of experiment in this study are consistent with previously published work 20, 21, 24, 42, 62, 63 . For lysolecithin treatment experiments, samples were randomly distributed between the two conditions and data collection and analysis were performed blinded, and unblinded for all other experiments.
Accession codes. Gene expression data are available in the Gene Expression Omnibus under accession number GSE115011.
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Data availability
Gene expression data have been deposited in the Gene Expression Omnibus under accession number GSE115011. The data that support the findings of this study are available on reasonable request from the corresponding author. 
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